Akseli Hemminki
Oprichter bij TILT Biotherapeutics Oy
Profiel
Akseli Hemminki is the founder of TILT Biotherapeutics Oy, where he currently serves as the Chief Executive Officer & Director.
TILT Biotherapeutics Oy was founded in 2013.
Dr. Hemminki is also the founder of Targovax Oy.
In addition to his founding positions, Dr. Hemminki has worked as a Research Team Leader at The University of Alabama.
Actieve functies van Akseli Hemminki
| Bedrijven | Functie | Begin |
|---|---|---|
TILT Biotherapeutics Oy
 TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | Oprichter | 01-01-2013 |
Eerdere bekende functies van Akseli Hemminki
| Bedrijven | Functie | Einde |
|---|---|---|
| The University of Alabama | Corporate Officer/Principal | - |
Targovax Oy
 Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Targovax Oy
Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Health Technology |
TILT Biotherapeutics Oy
TILT Biotherapeutics Oy Pharmaceuticals: MajorHealth Technology TILT Biotherapeutics Oy is a preclinical stage company working in the field of cancer immunotherapy. It develops genetically modified oncolytic viruses that enhance T-cell therapies for cancer treatment. The company was founded by Akseli Hemminki in 2013 and is headquartered in Helsinki, Finland. | Health Technology |
